EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple‐Negative Breast Cancer Drug Delivery

Gaya S Dasanayake, Christine M Hamadani, Fikir Hailu, Iyanuoluwani Owolabi, Mira Patel, Claylee M Chism, Veeresh Toragall, Sandeep K Misra, Sushil K Mishra, Mohamed E Jahan, Priyavrat Vashisth, Joshua S Sharp und 5 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Gaya S Dasanayake und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Mississippi, University, MS, 38677, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nanoparticles, Ionic Liquids, Drug Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted drug delivery seeks to revolutionize disease treatment by enhancing therapeutic efficacy and specificity. However, developing and achieving precisely targeted delivery remains a significant challenge, particularly in cancers such as triple‐negative breast cancer (TNBC), which lack traditional markers for targeted delivery. TNBC cells overexpress glucose transport proteins (GLUTs) on their surfaces, providing an opportunity for targeting. Herein, sugar‐based ionic liquids (Glyco‐ILs or GILs) are developed and used to modify poly (lactic‐co‐glycolic acid) (PLGA) nanocarriers (NPs), show enhanced affinity and selectivity towards TNBC cells and human and mouse erythrocytes. Inhibition assays, molecular docking simulations, and liquid chromatography‐mass spectrometry (LCMS) analysis data show that the enhanced nanoparticle affinity for TNBC cells is likely due to a combination of specific binding interactions with GLUT transporters and endocytosis. The observed RBC affinity is evidenced to be driven by interactions with RBC membrane GLUTs along with their unique serum protein corona on the nanoparticle surface. In vivo, experiments in a healthy BALB/c mouse model show that Glyco‐IL‐NPs demonstrate longer retention time in the bloodstream and a significant reduction in liver accumulation relative to the control. These findings suggest that Glyco‐IL‐modified PLGA nanoparticles (GIL‐NPs) hold a promising approach for selective drug delivery, particularly in cells that overexpress GLUTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsNanoparticlesIonic LiquidsDrug Delivery SystemsAnimalsHumansMicePolylactic Acid-Polyglycolic Acid CopolymerFemaleCell Line, TumorMice, Inbred BALB CDrug CarriersErythrocytesDoxorubicin

Stichwörter der Autor:innen

Glyco scienceionic liquidsnanoparticlestriple‐negative breast cancer

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerIonic LiquidsDrug CarriersDoxorubicin

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Mississippi, University, MS, 38677, USA.
  • School of Biological, Environmental, Earth Sciences (BEES), University of Southern Mississippi, Hattiesburg, MS, 39406, USA.
  • Department of Biomedical Engineering, University of Mississippi, University, MS, 38677, USA.
  • Department of BioMolecular Sciences, University of Mississippi, University, MS, 38677, USA.

ORCID-Profile: Eden E L Tanner

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Dasanayake, G. S., Hamadani, C. M., Hailu, F., Owolabi, I., Patel, M., Chism, C. M., Toragall, V., Misra, S. K., Mishra, S. K., Jahan, M. E., Vashisth, P., Sharp, J. S., Flynt, A., Doerksen, R. J., Werfel, T. A., Singh, G., & Tanner, E. E. L. (2025). Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple‐Negative Breast Cancer Drug Delivery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500592

Vancouver

Dasanayake GS, Hamadani CM, Hailu F, Owolabi I, Patel M, Chism CM, et al. Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple‐Negative Breast Cancer Drug Delivery. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500592

BibTeX
@article{Dasanayake2025,
  author = {Dasanayake, Gaya S and Hamadani, Christine M and Hailu, Fikir and Owolabi, Iyanuoluwani and Patel, Mira and Chism, Claylee M and Toragall, Veeresh and Misra, Sandeep K and Mishra, Sushil K and Jahan, Mohamed E and Vashisth, Priyavrat and Sharp, Joshua S and Flynt, Alex and Doerksen, Robert J and Werfel, Thomas A and Singh, Gagandeep and Tanner, Eden E L},
  title = {Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple‐Negative Breast Cancer Drug Delivery},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500592}
}
Kostenlos starten →